Alcon makes final push for WaveLight

Article

Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.

Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.

Upon settlement of all tendered shares, Alcon will own 77.4% of the outstanding WaveLight shares and shareholders who tendered their shares under the offer will automatically receive payment.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.